Ko Okumura

USPTO Granted Patents = 13 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 108(Granted Patents)

Location History:

Bunkyo, JP (1993)
Chiba, JP (1999 - 2000)
Tokyo JP (2002)
Bunkyo-ku, Tokyo-to, JP (2004)
Tokyo, JP (2000 - 2019)

Company Filing History:

Sumitomo Electric Industries, Limited

Yoshitomi Pharmaceutical Industries, Ltd.

Japan Science and Technology Agency

The Green Cross Corporation

patents

10. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12397054 - Antibody capable of inducing immune tolerance produced using cell mixture having complexed state, and induced lymphocyte or cell therapeutic agent and cell therapy method each using induced lymphocyte (2025-08-26),

2. 12234287 - Method for eliciting infectious immunological tolerance (2025-02-25),

3. 12139537 - Antibody inducing immune tolerance, induced lymphocyte, and cell therapy agent therapeutic method using induced lymphocyte (2024-11-12),

4. 10258982 - Combined-blade open flow path device and joined body thereof (2019-04-16),

5. 10195271 - Antibody titer-increasing agent using lactic acid bacterium (2019-02-05),

6. 6946255 - Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof (2005-09-20),

7. 6777540 - Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand (2004-08-17),

8. 6426403 - TRAF family molecules, polynucleotides encoding them, and antibodies against them (2002-07-30),

9. 6090384 - Antiallergic compostion (2000-07-18),

10. 6068841 - Antibodies to Fas-L for treatment of hepatitis (2000-05-30),

11. 5874404 - Immunoglobulin E receptor .alpha.-chain inhibits IgE production and (1999-02-23),

12. 5855888 - Drug for the treatment of rheumatoid arthritis (1999-01-05),

13. 5232832 - Antibody reactive to hamster immunoglobulins and assay using same (1993-08-03),

Title: Ko Okumura: Innovator in Immunological Tolerance

Introduction

Ko Okumura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the area of immune tolerance. With a total of 13 patents to his name, Okumura's work has the potential to impact therapeutic approaches for various medical conditions.

Latest Patents

Okumura's latest patents include groundbreaking innovations such as an antibody capable of inducing immune tolerance produced using a cell mixture in a complexed state. This invention focuses on a pharmaceutical composition for antigen-specific immune tolerance or immune suppression. The composition comprises CD-positive anergy T cells, which are induced by an antibody that inhibits the interaction between CD80/CD86 and CD28. Another notable patent involves a method for eliciting infectious immunological tolerance, which demonstrates that immunological tolerance can persist even after the cells derived from the cell preparation have disappeared from the recipient.

Career Highlights

Throughout his career, Ko Okumura has worked with various organizations, including Junten Bio Co., Ltd. His innovative research has positioned him as a key figure in the development of therapies aimed at managing immune responses.

Collaborations

Okumura has collaborated with notable professionals in his field, including Hideo Yagita and Motomi Nakata. These collaborations have further enriched his research and contributed to advancements in immunological therapies.

Conclusion

Ko Okumura's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic strategies aimed at achieving immune tolerance.

This text is generated by artificial intelligence and may not be accurate.